Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-12-15

FDA Approved: NALBUPHINE HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for nalbuphine hydrochloride by Hospira, updating labeling for this generic analgesic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nalbuphine hydrochloride (nalbuphine hydrochloride)

Snippet

SUPPL AP for NALBUPHINE HYDROCHLORIDE (NALBUPHINE HYDROCHLORIDE)